Mark Shackleton
Impact in
- Oncology top 0.2%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Papers in ⓘ
- Oncology 56
- Cutaneous Melanoma Detection and Management 17
- Cancer Cells and Metastasis 17
- Cancer Immunotherapy and Biomarkers 14
- CAR-T cell therapy research 9
- Immunology 22
- Immunotherapy and Immune Responses 16
- Co-authors
- Elsa Quintana (7 shared papers)Sean J. Morrison (6 shared papers)François Vaillant (7 shared papers)Julia Stingl (4 shared papers)Geoffrey J. Lindeman (9 shared papers)Jane E. Visvader (9 shared papers)Marie-Liesse Asselin-Labat (7 shared papers)Timothy M. Johnson (5 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Oncogene (4 papers)Cancer Research (3 papers)Nature (3 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Mark Shackleton
80 papers receiving 7.9k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Oncology 5.4k
- Cancer Research 1.9k
- Molecular Biology 4.4k
- Immunology 1.1k
- Cell Biology 707
Countries citing papers authored by Mark Shackleton
This map shows the geographic impact of Mark Shackleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Shackleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Shackleton more than expected).
Fields of papers citing papers by Mark Shackleton
This network shows the impact of papers produced by Mark Shackleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Shackleton. The network helps show where Mark Shackleton may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Shackleton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Generation of a functional mammary gland from a single stem cell Hit paper breakdown → | 2006 | 1522 |
| 2 | Efficient tumour formation by single human melanoma cells Hit paper breakdown → | 2008 | 1327 |
| 3 | Purification and unique properties of mammary epithelial stem cells Hit paper breakdown → | 2006 | 1213 |
| 4 | Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution Hit paper breakdown → | 2009 | 871 |
| 5 | Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation Hit paper breakdown → | 2006 | 659 |
| 6 | 2010 | 446 | |
| 7 | 2008 | 255 | |
| 8 | 2006 | 220 | |
| 9 | 2010 | 118 | |
| 10 | 2015 | 106 | |
| 11 | 2003 | 96 | |
| 12 | The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand. | 2004 | 96 |
| 13 | 2011 | 84 | |
| 14 | 2012 | 78 | |
| 15 | Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma. | 2003 | 64 |
| 16 | 2020 | 61 | |
| 17 | 2012 | 58 | |
| 18 | 2015 | 52 | |
| 19 | 2014 | 47 | |
| 20 | 2016 | 43 |
About Mark Shackleton
Mark Shackleton is a scholar working on Oncology, Immunology, Dermatology, Cancer Research and Ophthalmology, having authored 90 papers that have together received 8.0k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (18 papers), Cutaneous Melanoma Detection and Management (17 papers), Cancer Cells and Metastasis (17 papers), Immunotherapy and Immune Responses (16 papers), Cancer Immunotherapy and Biomarkers (14 papers), CAR-T cell therapy research (9 papers), Cancer Genomics and Diagnostics (7 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). The work is most often cited by research in Oncology (5.4k citations), Cancer Research (1.9k citations), Molecular Biology (4.4k citations), Immunology (1.1k citations) and Cell Biology (707 citations). Mark Shackleton has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Elsa Quintana, Sean J. Morrison, François Vaillant, Julia Stingl, Geoffrey J. Lindeman, Jane E. Visvader, Marie-Liesse Asselin-Labat, Timothy M. Johnson, Douglas R. Fullen and Michael S. Sabel. Their work appears in journals such as Journal of Clinical Oncology, Oncogene, Cancer Research, Nature and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.